New pricing is up on the site! What's changed and why it's better for you: • One price per SKU - our lowest tier rate, extended to every partner. • A full QC panel on every lot - ID, purity, quantitation, endotoxin, and heavy metals, run at one of our partner third-party labs (ILS, Janoshik, or TrustPointe), with a Certificate of Analysis issued in your organization or brand name. • Vetted sourcing - every supplier facility is inspected for cGMP/ISO-compliant processes before a SKU makes the catalog. • Lot economics passed to you - we commit full production lots, and that volume is what makes the single low rate possible.

Need to call out most peptide testing labs for their terrible customer service/support. None of them are reliable or offer anything to be considered even decent. There's a lot of room for competition and improvement in this space.

Testing Lab: I'm afraid the ID, purity and mass testing failed. Me: 0mg

I'm just waiting for the massive tsunami of posts with snippets from this episode that are about to flood X from various peptide accounts reenforcing whatever arguments pro/con they're trying to make. 🍿

This is us btw

Most people don’t understand the challenges and complexities of putting together and streamlining a standards and protocols based supply chain internationally. We do.

We're adding @ILSLabs to our list of peptides testing partner labs. Their standards and quality of testing have gained recognition in the space in the last few months. Happy to have another US-based lab part of our network.

Trust but verify is everything in this business.

Grey market peptide sourcing is broken. Most operators are stuck dealing with fragmented suppliers, self-issued CoAs, unclear batch handling, payment friction, and inconstant accountability when something goes wrong. ClearBatch was built to fix that. We act as the sourcing layer between researchers/lab operators and our own vetted network of peptide manufacturers: ✅ Multi-supplier network aggregation for best per-SKU pricing ✅ Independent third-party testing on every batch ✅ Verifiable CoAs from reputable labs ✅ Identity, purity, endotoxin heavy metals testing ✅ North American invoicing clean payment rails ✅ Batch traceability from production to delivery For serious researchers and operators who want cleaner sourcing, stronger documentation, and fewer supplier headaches: clearbatch.net/sourcing

Really interesting that even the smallest dose delivered a 20% weight reduction with fewer side effects. That would probably work for most folks.

Lilly’s Phase 3 TRIUMPH-1 data put Retatrutide firmly in the spotlight: • Up to 28.3% average weight loss at 80 weeks • 45.3% of participants on 12 mg achieved ≥30% weight loss • Up to 30.3% average loss in the 104-week extension We summarized the key results in this infographic for researchers tracking the next wave of incretin-based metabolic science.

Big day, we're launching the peptides vetted sourcing service ClearBatch is the sourcing layer between research and lab operators and the international supplier landscape: vetted manufacturers, independent third-party testing on every batch, and customer-name Certificates of Analysis you can publish with confidence. clearbatch.net/sourcing

The seven additional Reta TRIUMPH readouts queued through 2026 will reshape the dosing conversation more than TRIUMPH-4 did. Type 2 diabetes. Sleep apnea. Chronic low back pain. Metabolic liver disease. Each indication likely wants a different titration ramp.

When we test peptides across lots the post-reconstitution stability curves diverge faster than most users assume. Light exposure. Concentration. Temperature. All three matter. The 28 day rule is a heuristic, but good rule to follow. Some molecules hold longer. Others fail earlier.

The lineage from sermorelin and ipamorelin into the current GH secretagogue stack is one of the cleanest case studies of how peptide science actually iterates. The field shows up later but the chemistry was being run for 20 years.

The patient picking BPC-157 over a statin is the trust crisis the field has been describing for two years. The volume of RCT evidence inverted against public trust is the real story, not the peptide. The information landscape underneath the choices being made.

Patients keeping the peptide and dropping the statin tells you where this is going. BPC-157. Tesamorelin. CJC-1295. Ipamorelin. GHK-Cu. Tirzepatide. Mainstream medicine writes the prescription and the timeline writes the protocol. We're starting some difference conversations.

Reta TRIUMPH-4 weight loss number is everywhere. The dysesthesia number isnt. 28.7 percent weight loss at 12mg. 2 0.9 percent abnormal skin sensations at 12mg. 0.7 percent on placebo. Mostly mild, rarely caused dropout. The second number is the dose conversation now.